Objectives: To discern the relevance of ST648 extended-spectrum b-lactamase (ESBL)-producing Escherichia coli as a putative new group of multiresistant and extraintestinal pathogenic strains in animals, its frequency, ESBL types, antimicrobial resistance patterns and virulence gene (VG) profiles should be determined and compared with ST131 strains from the same collection of strains.
Introduction
The global emergence of extended-spectrum b-lactamase (ESBL)-producing Escherichia coli is generally thought to be multiclonal. 1 However, the great expansion of the highly virulent clonal group B2-O25b:H4-ST131, particularly in humans 2 and less frequently in animals 2, 3 and the environment, 4 has presented a major public health threat in the past decade. In a so far unique way, this pandemic extraintestinal pathogenic E. coli (ExPEC) clone effectively combined multidrug resistance and virulence and thus contradicted the common belief that a trade-off between antimicrobial resistance and virulence is an obligatory event. 5 Apart from phylogroup B2 strains, group D strains are also recognized as potent extraintestinal pathogens and these two groups account for approximately two-thirds of all ExPEC infections, including urinary tract infections, bacteraemia and meningitis, both in humans and animals. 2 Distinct genotypes, such as ST405 and ST648, which belong to this second-most virulent ExPEC group D, were identified recently. 1 In particular, ST648 strains with an ESBL phenotype have been observed globally in human patients and more incidentally from chicken and pigs in Europe and from wild birds in Germany and Mongolia. 6 -9 What is widely unknown, however, is the distribution of ESBLproducing ST648 strains among companion animals, which are more and more considered an important source of human infections both by ExPEC and by multiresistant E. coli strains in general. 10 The aim of the present study was to assess the relevance of ST648 strains as a new group of multiresistant and virulent strains in animals. ST648 and ST131 isolates were determined among clinical ESBL-producing E. coli isolates. ESBL types, plasmid replicon types, macrorestriction and phenotypic resistance patterns and, finally, ExPEC-related virulence genes (VGs) were explored to determine the clonal relationship and virulence potential of the strains.
Materials and methods

Bacterial isolates and determination of phenotypic resistance
Non-repetitive ESBL-producing E. coli isolates (n¼1152) originating from 11 European countries (Germany, 876; Italy, 113; France, 54; the Netherlands, 49; Austria, 21; Denmark, 15; Spain, 12; Luxembourg, 7; Poland, 3; Finland, 1; Sweden, 1) were consecutively isolated at a veterinary diagnostic laboratory from sample material provided by .750 veterinary clinics between April 2008 and April 2011. Bacterial species identification and susceptibility testing was performed using the Vitek w 2 system (bioMé rieux, Germany; according to the time of isolation, AST cards N118 or GN38 were used) and ESBL production was confirmed using CLSI guidelines. 11 Isolates were from dogs (669), cats (268), horses (131), cattle (39) and various other species (45). They were implicated in urinary tract infection (298), enteritis (274), skin and soft tissue infection (232), respiratory tract infection (113), genital tract infection (47) and various other diseases (188). In addition, 10 ST648 ESBL-producing E. coli isolates were used for comparative analyses (see Figure 1) , including human clinical isolates from the USA (YD28 and EC7), 12, 13 Germany (IMT21183) and China (WCE227) 7 and wild avian isolates from Germany (IMT16316, IMT16357, IMT16343 and IMT16352) and Mongolia (IMT23464 and IMT23463). 9, 14 Phylogenetic grouping, multilocus sequence typing (MLST) and serotyping Phylogenetic grouping of ESBL-producing E. coli was done by the triplex PCR method. 15 Partial MLST analysis (adk and mdh genes) was performed for EcoR group D and B2 strains (http://mlst.ucc.ie/mlst/mlst/dbs/Ecoli). Strains initially possessing adk and mdh alleles, predictive for ST648 and ST131, respectively, were subjected to complete MLST analysis. Sequences were analysed by Ridom SeqSphere 0.9.19 (http://www3. ridom.de/seqsphere). Serotyping was performed as described previously. 3 Molecular virulence and resistance determinants and conjugation assays E. coli ST648 and ST131 isolates were examined for 57 genes associated with the ExPEC group and linked with intestinal pathovars, respectively, by multiplex and single PCR following established protocols ( Figure S1 , available as Supplementary data at JAC Online). 3 Resistance determinants were explored by PCR and sequencing as described previously. 3 Transfer of b-lactam resistance was achieved by the filter mating method using sodium azide-resistant recipient strain E. coli K12-J53. Plasmid replicon typing was done by PCR. 16 
Clonal analysis by PFGE
Macrorestriction analysis was performed as described previously. 3 XbaI-generated PFGE profiles were compared using BioNumerics software (Version 6.6, Applied Maths, Belgium) and cluster analysis of Dice similarity indices based on UPGMA. The definition of a PFGE cluster was based on a Dice similarity index ≥85% (tolerance 1.0; optimization 1.5).
Results
Phylogenetic distribution of ESBL-producing E. coli
Two hundred (17.4%) of the 1152 ESBL-producing E. coli were determined as EcoR group D strains and 126 (10.9%) as group B2 strains. The remaining isolates belonged to groups A (60.2%) and B1 (11.5%). Forty (20%) group D strains harboured alleles adk 92 and mdh 70 and all were confirmed as ST648 strains, which accounted for 3.5% of the entire ESBL-producing E. coli collection. Among the B2 strains, 32 isolates (2.8% of the entire collection) were assigned to ST131.
Determination of resistance phenotypes and genotypes
Overall, D-ST648 ESBL-producing animal E. coli isolates revealed higher MICs of several antimicrobial substances than the B2-ST131 strains identified in this study. Resistance against different fluoroquinolones added up to 97.7% among ST648 strains versus 87.5% in ST131 strains. Other resistances were as follows: gentamicin, 72.3% versus 34.4% (P ¼0.001); tetracycline, 91.5% versus 62.5% (P ¼ 0.003); tobramycin, 57.5% versus 56.3%; and trimethoprim/sulfamethoxazole, 80.9% versus 59.4% (P ¼ 0.05). All ST648 isolates were highly susceptible to carbapenems. The majority of ST648 isolates from domestic animals harboured bla CTX-M-15 , located on conjugative plasmids of incompatibility groups FIA, FIB, and FII (single and multiple replicons), and I1 replicon type (Table 1) . Although CTX-M-15 was the predominant b-lactamase in both sequence type groups, ST648 strains displayed a lower variety in ESBL types (CTX-M-1, 10.0%; CTX-M-3, 2.5%; CTX-M-14, 12.5%; CTX-M-15, 72.5%; and CTX-M-61, 2.5%) compared with ST131 strains (CTX-M-1, 9.4%; CTX-M-2, 3.1%; CTX-M-14, 18.8%; CTX-M-15, 46.9%; CTX-M-27, 15.6%; CTX-M-55, 3.1%; and SHV-12, 3.1%).
Clonal analysis by PFGE
Ten PFGE clusters of clonally related groups of 2 (clusters A, C, F, G and H), 7 (B), 11 (D and E), 4 (I) and 6 (J) strains, respectively, were observed among the ST648 isolates ( Figure 1 Figure 1 . Dendrogram showing the relationship of ESBL-producing D-ST648 E. coli isolates based on XbaI-generated PFGE profiles. According to a similarity index of ≥85%, E. coli strains are separated into 10 PFGE clusters (A -J) and one singleton (S) isolate. UTI, urinary tract infection; RTI, respiratory tract infection; STI, soft tissue infection; NM, non-motile; NT, not typeable. Colours: green¼domestic animal; blue¼human; and red¼wild bird. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC. 
VG typing
ST648 ESBL-producing E. coli revealed a heterogeneous VG profile and possessed 6 -24 genes each (median number 11.0+4.3). Seventeen isolates could be identified as ExPEC as they possessed two or more of the VGs necessary for fulfilling previously defined ExPEC criteria (papC, iutA, kpsMTII, sfa/foc and afa/dra).
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Although ST131 strains harboured an overall higher number of VGs (15.0+4.6), single strains showed considerable overlaps with ST648 strains ( Figure S1 , available as Supplementary data at JAC Online).
Discussion
The frequent occurrence of D-ST648-CTX-M-15 isolates among clinical samples from predominantly companion animals and horses underlines the wide dissemination of this ESBL-producing genotype, which has previously been detected in livestock, wildlife and also humans. 7,18 -20 Only very recently, a D-ST648-CTX-M-15 isolate was also reported from a cat with chronic cystitis in Switzerland. 21 Nicolas-Chanoine et al. 19 were the first to describe a CTX-M-1-O25:H4-ST648 strain from human urine in Spain. Since then, a number of studies have identified this sequence type among ESBL and NDM carbapenemase producers isolated from human patients. 1, 22 Together with our findings, this supports the basic idea that non-B2 ExPEC-like lineages are prone to successfully enter a variety of ecological niches and at the same time might reveal a new group of clinically relevant strains.
The predominance of CTX-M-15 both in the animal ST648 and ST131 strains underlines the overall finding that this otherwise human-linked b-lactamase type prevails among companion animal isolates, whereas CTX-M-1 is by far the most common ESBL type in livestock. 1, 23 The global expansion of ST131 in humans has partly been associated with the presence of CTX-M-15.
2 A comparable high proportion of CTX-M-15 among ST648 strains indicates a similar linkage between genotype and ESBL type, which could probably drive its further expansion. The zoonotic potential of ST648 ESBL-producing strains is indicated by the detection of clonal clusters shared by strains of humans, domestic and wild animals. An interspecies as well as a mutual exchange of such strains between clinical, community and environmental surroundings seems very likely. One limitation in this conclusion refers to those PFGE clusters that contain strains of different serotypes. Whether this is due to separate entities of highly related strains or reflects minor evolutionary changes after entry of a common ancestor in different habitats remains unclear.
The carriage by ESBL-producing ST131 isolates of VGs, which are required to cause extraintestinal infections, together with their phylogenetic background and multiresistance phenotype was deemed to be a reasonable explanation for the global success of this clone. 24 ST131 is generally much less abundant in animals than in humans, 1, 2 but in the present study animal isolates of this clone also revealed high numbers of ExPEC-related VGs. Notably, a subgroup of animal ST648 isolates revealed a comparable VG profile. Thus, it is likely that such strains could become increasingly associated with severe infections in animals and humans in the future. Companion animals unequivocally c Genes underlined as well as bla CTX-M genes were identified in both wild-type and transconjugants.
CTX-M-producing Escherichia coli ST648 constitute a relevant source of putatively zoonotic E. coli genotypes and ESBL types, respectively. Their exact part in the complex field of antimicrobial resistance deserves proper attention, particularly as they live in much closer contact to humans than livestock do.
